Sign up
Pharma Capital

MMJ PhytoTech enters collaboration

The halt will remain in place until Tuesday 14th November 2017.
1510269946_agreement-7.jpg
The company's shares are in pre-open

MMJ PhytoTech Ltd (ASX:MMJ) is preparing to outline an investment and collaboration arrangement, with the ASX granting the company a trading halt to finalise.

MMJ owns 59% of Harvest One Cannabis Inc. (TSX-V:HVST).

The halt will remain in place until the opening of trade on Tuesday 14th November 2017, or earlier if an announcement is made to the market.

View full profile

Timeline

View All

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.